Gestational Diabetes Monitoring and Management

The primary goal is to predict the clinical outcomes of mother and baby using blood glucose and other routinely collected clinical data in pregnancy to predict adverse outcomes at birth in women with GDM. The secondary goal is to develop models to predict optimal blood glucose testing schedules for pregnant women. Exploratory Objectives are (1) to understand patterns of dosage and / or medication choice and (2) to describe different phenotypes of gestational diabetes based on multiple data input.

NCT Number	NCT06963528
Lead Sponsor	University of Oxford Collaborators: Royal Academy of Engineering, Oxford University Hospitals NHS Trust
Conditions	Gestational Diabetes, Pregnancy Complications, Pregnancy in Diabetic, Pregnancy, High Risk, Diabetes Complications, Pregnancy Induced Hypertension, Pregnancy Weight Gain, Gestational Hypertension +11 more
Enrollment	1,800 participants
Start Date	2021-12-01
Primary Completion	2023-09-01 (estimated)
Study Completion	2025-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-05-18